Gaby Kelly Bezerra de Macedo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gaby Kelly Bezerra de Macedo has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Karolinne Souza Monteiro
Universidade Federal do Rio Grande do Norte, Brazil
4 shared publications - Mayara Fabiana Pereira Costa
Postgraduate Program in Physical Therapy, Faculty of Health Sciences of Trairi, Federal University of Rio Grande do Norte, Santa Cruz, Rio Grande do Norte, Brazil
3 shared publications - Alana Vallessa Bernardo Silva1 shared publication
- Ana Tereza Do Nascimento Sales Figueiredo Fernandes
Department of Physiotherapy Paraíba State University (UEPB) Campina Grande Paraíba Brazil
1 shared publication Dauane Pontes Costa
1 shared publicationEsdras David Silva de Souza
1 shared publication
Latest Publications
- Open Access
Comparison between the thoracoabdominal rebalancing (TAR) method and the slow expiratory flow acceleration (SEFA) technique in preterm newborns: protocol for a randomised controlled clinical trial
Introduction: Preterm newborns (PTNB) present respiratory immaturity and increased susceptibility to muscle fatigue. The thoracoabdominal rebalancing (TAR) method is a physiotherapeutic intervention developed in Brazil that aims to reorganise the synergy of the thoracoabdominal muscles and reduce the effort of the respiratory muscles, a benefit that is particularly important for PTNB; however, the evidence regarding its effectiveness in this population remains inconclusive. Therefore, this study aims to compare the short-term effects of the TAR method and the slow expiratory flow acceleration (SEFA) technique in improving respiratory distress and peripheral oxygen saturation (SpO2) in PTNB admitted to neonatal intensive care unit (NICU). Methods and analysis: The study will be a randomised, controlled, two-arm, parallel-group, single-blind clinical trial. 68 participants will be randomly assigned to one of the two treatment groups. Group 1 will receive four handling techniques of the TAR method for 10 min, followed by the rhinopharyngeal retrograde clearance with saline instillation (RRC+I) technique. Group 2 will receive the SEFA technique for 10 min, also followed by RRC+I. Primary outcomes are respiratory distress and SpO2. Secondary outcomes are respiratory rate (RR), heart rate (HR), pain, behaviour and diaphragmatic excursion. Assessments will be conducted by a blinded researcher at baseline (T0), immediately after the intervention (T1) and at the 30-minute follow-up (T2). Data will be described using measures of central tendency and dispersion and absolute and relative frequencies. An intention-to-treat analysis will be performed, and intragroup and intergroup comparisons will be assessed using generalised estimating equations (GEE). Ethics and dissemination: The Research Ethics Committee of the Faculty of Health Sciences of Trairi of the Federal University of Rio Grande do Norte approved this study (number 8,055,786). The results will be disseminated through peer-reviewed journal publications, scientific conferences presentations and knowledge translation to the public. Trial registration number: This study was registered on Brazilian Registry of Clinical Trials (ReBEC) on 9 January 2026 (RBR-3gbsyc2).
Open AccessComparison between the thoracoabdominal rebalancing (TAR) method and the slow expiratory flow acceleration (SEFA) technique in preterm newborns: protocol for a randomised controlled clinical trial
Introduction: Preterm newborns (PTNB) present respiratory immaturity and increased susceptibility to muscle fatigue. The thoracoabdominal rebalancing (TAR) method is a physiotherapeutic intervention developed in Brazil that aims to reorganise the synergy of the thoracoabdominal muscles and reduce the effort of the respiratory muscles, a benefit that is particularly important for PTNB; however, the evidence regarding its effectiveness in this population remains inconclusive. Therefore, this study aims to compare the short-term effects of the TAR method and the slow expiratory flow acceleration (SEFA) technique in improving respiratory distress and peripheral oxygen saturation (SpO2) in PTNB admitted to neonatal intensive care unit (NICU). Methods and analysis: The study will be a randomised, controlled, two-arm, parallel-group, single-blind clinical trial. 68 participants will be randomly assigned to one of the two treatment groups. Group 1 will receive four handling techniques of the TAR method for 10 min, followed by the rhinopharyngeal retrograde clearance with saline instillation (RRC+I) technique. Group 2 will receive the SEFA technique for 10 min, also followed by RRC+I. Primary outcomes are respiratory distress and SpO2. Secondary outcomes are respiratory rate (RR), heart rate (HR), pain, behaviour and diaphragmatic excursion. Assessments will be conducted by a blinded researcher at baseline (T0), immediately after the intervention (T1) and at the 30-minute follow-up (T2). Data will be described using measures of central tendency and dispersion and absolute and relative frequencies. An intention-to-treat analysis will be performed, and intragroup and intergroup comparisons will be assessed using generalised estimating equations (GEE). Ethics and dissemination: The Research Ethics Committee of the Faculty of Health Sciences of Trairi of the Federal University of Rio Grande do Norte approved this study (number 8,055,786). The results will be disseminated through peer-reviewed journal publications, scientific conferences presentations and knowledge translation to the public. Trial registration number: This study was registered on Brazilian Registry of Clinical Trials (ReBEC) on 9 January 2026 (RBR-3gbsyc2).
- Open Access
- 5 January 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003505
Use of high-frequency chest wall oscillation therapy in infants: protocol for a feasibility randomised controlled clinical trial
Introduction: Since the inflammatory response increases the production and accumulation of mucus in the airways during respiratory infections, conventional and unconventional techniques of secretion removal are used. High-frequency chest wall oscillation is an effective strategy for secretion removal; however, it presents barriers due to the high cost. In Brazil, the Expector was developed using a kangaroo-vest interface as an accessible alternative; however, studies are needed to evaluate the use of Expector in infants. The aim of this study was to assess the feasibility and usability of the Expector device in healthy infants. Methods and analysis: For this feasibility randomised controlled clinical trial, 30 participants aged 3–6 months will be divided into three groups. Two experimental groups will use the Expector device (kangaroo baby-carrier version) with different configurations of the minivibrating motors (ie, totally activated and upper half of motors activated). The device will be deactivated for the control group. The following parameters will be assessed before the test, every 5 min during 15 min of device use and for 15 min after its use: heart rate, respiratory rate, peripheral oxygen saturation, pulmonary auscultation, sleep/wakefulness state, pain and parental satisfaction. Data will be described using measures of central tendency and dispersion and absolute and relative frequencies. Statistical analysis will be performed using correlation and intra- and intergroup comparisons. This study will generate preliminary evidence regarding the feasibility of Expector (kangaroo baby-carrier version) for infants and allow randomised and controlled studies using this technology. Ethics and dissemination: The Ethics Committee of the Faculty of Health Sciences of Trairi of the Federal University of Rio Grande do Norte approved this study (Number 5636504). Findings will be disseminated through peer-reviewed journal publications, scientific conference presentations and knowledge translation to the public via social media. Trial registration number: This feasibility randomised controlled clinical trial was registered in the Brazilian Registry of Clinical Trials (REBEC) (Number RBR-5r8v8qz).
- 5 January 2026
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 13 (1) , e003505
Open AccessUse of high-frequency chest wall oscillation therapy in infants: protocol for a feasibility randomised controlled clinical trial
Introduction: Since the inflammatory response increases the production and accumulation of mucus in the airways during respiratory infections, conventional and unconventional techniques of secretion removal are used. High-frequency chest wall oscillation is an effective strategy for secretion removal; however, it presents barriers due to the high cost. In Brazil, the Expector was developed using a kangaroo-vest interface as an accessible alternative; however, studies are needed to evaluate the use of Expector in infants. The aim of this study was to assess the feasibility and usability of the Expector device in healthy infants. Methods and analysis: For this feasibility randomised controlled clinical trial, 30 participants aged 3–6 months will be divided into three groups. Two experimental groups will use the Expector device (kangaroo baby-carrier version) with different configurations of the minivibrating motors (ie, totally activated and upper half of motors activated). The device will be deactivated for the control group. The following parameters will be assessed before the test, every 5 min during 15 min of device use and for 15 min after its use: heart rate, respiratory rate, peripheral oxygen saturation, pulmonary auscultation, sleep/wakefulness state, pain and parental satisfaction. Data will be described using measures of central tendency and dispersion and absolute and relative frequencies. Statistical analysis will be performed using correlation and intra- and intergroup comparisons. This study will generate preliminary evidence regarding the feasibility of Expector (kangaroo baby-carrier version) for infants and allow randomised and controlled studies using this technology. Ethics and dissemination: The Ethics Committee of the Faculty of Health Sciences of Trairi of the Federal University of Rio Grande do Norte approved this study (Number 5636504). Findings will be disseminated through peer-reviewed journal publications, scientific conference presentations and knowledge translation to the public via social media. Trial registration number: This feasibility randomised controlled clinical trial was registered in the Brazilian Registry of Clinical Trials (REBEC) (Number RBR-5r8v8qz).
- 1 January 2023
- Published by SCISAUDE
RELAÇÃO ENTRE AUTOEFICÁCIA E QUALIDADE DE VIDA EM CRIANÇAS E ADOLESCENTES COM DOENÇAS RESPIRATÓRIAS CRÔNICAS
Publique sua obra como capitulo de livro no SCISAÚDE. DOI. Ficha Catalográfica. ISBN. Fique por dentro de nosso congressos @scisaude
- 1 January 2023
- Published by SCISAUDE
RELAÇÃO ENTRE AUTOEFICÁCIA E QUALIDADE DE VIDA EM CRIANÇAS E ADOLESCENTES COM DOENÇAS RESPIRATÓRIAS CRÔNICAS
Publique sua obra como capitulo de livro no SCISAÚDE. DOI. Ficha Catalográfica. ISBN. Fique por dentro de nosso congressos @scisaude
- 1 January 2023
- Published by SCISAUDE
AVALIAÇÃO DA FUNCIONALIDADE DURANTE INTERNAÇÃO NA ENFERMARIA PEDIÁTRICA DE UM HOSPITAL UNIVERSITÁRIO: ESTUDO DE COORTE
Publique sua obra como capitulo de livro no SCISAÚDE. DOI. Ficha Catalográfica. ISBN. Fique por dentro de nosso congressos @scisaude
- 1 January 2023
- Published by SCISAUDE
AVALIAÇÃO DA FUNCIONALIDADE DURANTE INTERNAÇÃO NA ENFERMARIA PEDIÁTRICA DE UM HOSPITAL UNIVERSITÁRIO: ESTUDO DE COORTE
Publique sua obra como capitulo de livro no SCISAÚDE. DOI. Ficha Catalográfica. ISBN. Fique por dentro de nosso congressos @scisaude
- Open Access
- 1 January 2021
- Published by Editora Conhecimento Livre
Variação da frequência cardíaca durante testes de campo em indivíduos com DPOC
- 1 January 2021
- Published by Editora Conhecimento Livre
Open AccessVariação da frequência cardíaca durante testes de campo em indivíduos com DPOC